Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2016-07-11 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BRIE-COMTE-ROBERT (77170), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
GRANDE PHARMACIE DE BRIE COMTE ROBERT : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE BRIE COMTE ROBERT is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BRIE-COMTE-ROBERT (77170),
this company of category PME
shows in 2024 a net income positive of 129 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DE BRIE COMTE ROBERT (SIREN 821908290)
Indicator
2024
2023
2022
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
129 185 €
165 842 €
363 718 €
95 432 €
144 509 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, GRANDE PHARMACIE DE BRIE COMTE ROBERT generates positive net income of 129 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 145 k€ -> 129 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
129 185 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 34%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
33.815%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.672%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DE BRIE COMTE ROBERT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2022
2023
2024
Debt ratio
198.557
180.207
56.967
46.691
33.815
Financial autonomy
29.189
31.861
57.044
60.834
64.672
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
33.812024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good-6 pts over 3 years
In 2024, the debt ratio of GRANDE PHARMACIE DE BRIE ... (33.81) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.67%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+6 pts over 3 years
In 2024, the financial autonomy of GRANDE PHARMACIE DE BRIE ... (64.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 195.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
195.359
Liquidity indicators evolution GRANDE PHARMACIE DE BRIE COMTE ROBERT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2022
2023
2024
Liquidity ratio
139.069
172.309
256.285
256.399
195.359
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
195.362024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good-15 pts over 3 years
In 2024, the liquidity ratio of GRANDE PHARMACIE DE BRIE ... (195.36) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of GRANDE PHARMACIE DE BRIE COMTE ROBERT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of GRANDE PHARMACIE DE BRIE COMTE ROBERT is estimated at
1 803 518 €
(range 1 255 941€ - 2 698 166€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1255k€1803k€2698k€
1 803 518 €Range: 1 255 941€ - 2 698 166€
NAF 5 année 2024
Valuation method used
Net Income Multiple
129 185 €
×
14.0x
=1 803 518 €
Range: 1 255 941€ - 2 698 166€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE BRIE COMTE ROBERT with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE BRIE COMTE ROBERT
What is the revenue of GRANDE PHARMACIE DE BRIE COMTE ROBERT ?
The revenue of GRANDE PHARMACIE DE BRIE COMTE ROBERT is not publicly disclosed (confidential accounts filed with INPI).
Is GRANDE PHARMACIE DE BRIE COMTE ROBERT profitable?
Yes, GRANDE PHARMACIE DE BRIE COMTE ROBERT generated a net profit of 129 k€ in 2024.
Where is the headquarters of GRANDE PHARMACIE DE BRIE COMTE ROBERT ?
The headquarters of GRANDE PHARMACIE DE BRIE COMTE ROBERT is located in BRIE-COMTE-ROBERT (77170), in the department Seine-et-Marne.
Where to find the tax return of GRANDE PHARMACIE DE BRIE COMTE ROBERT ?
The tax return of GRANDE PHARMACIE DE BRIE COMTE ROBERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE BRIE COMTE ROBERT operate?
GRANDE PHARMACIE DE BRIE COMTE ROBERT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart